VYOME HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
VYOME HOLDINGS, INC. (HIND) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 425.94 thousand shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2019-02-22
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-09-30 was 0.00 shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-06-30 was 300.94K shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-03-31 was 125.00K shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2018 was 425.94K shares, a 2.83% increase from fiscal 2017.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 414.21K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 0.00 shares derived: sum of 2 quarters · filed 2019-02-22 | 300.94K shares derived: sum of 3 quarters · filed 2019-02-22 | 425.94K shares 10-K · filed 2019-02-22 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | 300.94K shares derived: sum of 2 quarters · filed 2018-11-02 | 425.94K shares 10-Q · filed 2018-11-02 | 447.15K shares derived: sum of 4 quarters · filed 2018-11-02 |
| 2018-06-30 | 300.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 425.94K shares 10-Q · filed 2018-08-02 | 447.15K shares derived: sum of 3 quarters · filed 2018-08-02 | |
| 2018-03-31 | 125.00K shares 10-Q · filed 2018-05-10 | 146.21K shares derived: sum of 2 quarters · filed 2018-05-10 | ||
| 2017-12-31 | 21.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | 414.21K shares 10-K · filed 2018-03-05 | ||
| 2017-09-30 | 393.00K shares 10-Q · filed 2017-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |